Literature DB >> 1478366

Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy?

M J Young1, A Veves, M G Walker, A J Boulton.   

Abstract

Transcutaneous oxygen, laser Doppler flowmetry, peroneal nerve motor conduction velocity and skin temperature were assessed in both legs of 34 diabetic patients, who had a mean age of 41 (range 29-77) years, and diabetes duration of 21 (3-34) years. Transcutaneous oxygen significantly correlated with peroneal nerve motor conduction velocity (r = 0.59 p < 0.001) and laser Doppler flowmetry (r = 0.7 p < 0.001). Laser Doppler flowmetry correlated weakly with peroneal motor conduction velocity, (r = 0.34 p < 0.05). In each patient the leg with the higher transcutaneous oxygen (mean 70.2 +/- 9.3 (SD) mmHg) had a significantly higher peroneal motor conduction velocity (45.3 +/- 7.1 vs 41.5 +/- 6.3 m/s, p < 0.01), than the leg with the lower transcutaneous oxygen (61.0 +/- 11.9 mmHg), though no difference in skin temperature was observed, 31.4 +/- 0.4 vs 31.1 +/- 0.5 degrees C. We then assessed the potential for reversibility of conduction velocity deficits in ten non-diabetic patients, aged 59 (52-77) years, undergoing unilateral femoro-popliteal bypass, measuring transcutaneous oxygen, peroneal nerve motor conduction velocity and skin temperature pre- and 6 weeks post-surgery. In the control leg (unoperated) there was no significant change in transcutaneous oxygen (63.2 +/- 8.8 vs 63.0 +/- 4.6 mm Hg), peroneal nerve motor conduction velocity (45.1 +/- 7.8 vs 43.4 +/- 7.2 m/s) or skin temperature (30.8 +/- 1.3 vs 30.2 +/- 1.2 degrees C) after surgery (all NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478366     DOI: 10.1007/bf00401368

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Morphological abnormalities in the sural nerve from patients with peripheral vascular disease.

Authors:  C Rodríguez-Sánchez; M Medina Sánchez; R A Malik; A K Ah-See; A K Sharma
Journal:  Histol Histopathol       Date:  1991-01       Impact factor: 2.303

3.  Upper extremity ischemic monomelic neuropathy: a complication of vascular access procedures in uremic diabetic patients.

Authors:  J E Riggs; A H Moss; D A Labosky; J H Liput; J J Morgan; L Gutmann
Journal:  Neurology       Date:  1989-07       Impact factor: 9.910

4.  Blood flow in the diabetic neuropathic foot.

Authors:  M E Edmonds; V C Roberts; P J Watkins
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

Review 5.  Peripheral diabetic neuropathy.

Authors:  H E Bays; M A Pfeifer
Journal:  Med Clin North Am       Date:  1988-11       Impact factor: 5.456

6.  Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy.

Authors:  S Tesfaye; N D Harris; R M Wilson; J D Ward
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

7.  Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting?

Authors:  A J Boulton; J H Scarpello; J D Ward
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

8.  Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy.

Authors:  P A Low; J D Schmelzer; K K Ward; J K Yao
Journal:  Am J Physiol       Date:  1986-01

Review 9.  Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?

Authors:  D A Greene; S A Lattimer; A A Sima
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

Review 10.  Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture.

Authors:  P J Dyck
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

View more
  15 in total

1.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

2.  The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients.

Authors:  A Veves; V M Donaghue; M R Sarnow; J M Giurini; D R Campbell; F W LoGerfo
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 3.  New concepts in diabetes mellitus. II: Complications.

Authors:  M Vanderpump; R Taylor
Journal:  Postgrad Med J       Date:  1994-07       Impact factor: 2.401

4.  Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.

Authors:  M A Cotter; K C Dines; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 5.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

6.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography.

Authors:  S Tesfaye; N Harris; J J Jakubowski; C Mody; R M Wilson; I G Rennie; J D Ward
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

7.  Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.

Authors:  E K Maxfield; N E Cameron; M A Cotter; K C Dines
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

9.  The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.

Authors:  N E Cameron; K C Dines; M A Cotter
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

10.  Endoneurial localisation of microvascular damage in human diabetic neuropathy.

Authors:  R A Malik; S Tesfaye; S D Thompson; A Veves; A K Sharma; A J Boulton; J D Ward
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.